skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover idioma: Inglês remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations
POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations
Material Type:
Artigo 		Adicionar ao Meu Espaço

POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations

Felizzi, F ; Manevy, F ; Di Maio, D

Value in health, 2022-01, Vol.25 (1), p.S47-S48 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis
POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis

Bellone, M ; Pradelli, L ; Sanfilippo, A ; Caputo, A ; Manevy, F ; Zerilli, A

Value in health, 2022-01, Vol.25 (1), p.S109-S109 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.